methionine has been researched along with osteoprotegerin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Huang, L; Kumta, SM; Lau, CP; Leung, PY; Ng, PK; Tsui, SK | 1 |
Chen, R; Du, H; Li, F; Lin, L; Luo, X; Ruan, C; Wu, S; Wu, Y; Zhang, X | 1 |
2 other study(ies) available for methionine and osteoprotegerin
Article | Year |
---|---|
Pamidronate, farnesyl transferase, and geranylgeranyl transferase-I inhibitors affects cell proliferation, apoptosis, and OPG/RANKL mRNA expression in stromal cells of giant cell tumor of bone.
Topics: Alkyl and Aryl Transferases; Apoptosis; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Caspases; Cell Division; Cell Survival; Diphosphonates; Drug Synergism; Enzyme Inhibitors; Farnesyltranstransferase; Gene Expression; Giant Cell Tumor of Bone; Humans; Methionine; Osteoprotegerin; Pamidronate; Prenylation; RANK Ligand; RNA, Messenger; S Phase; Tumor Cells, Cultured | 2011 |
Osteoprotegerin deficiency aggravates methionine-choline-deficient diet-induced nonalcoholic steatohepatitis in mice.
Topics: Animals; Choline; Choline Deficiency; Diet; Dual-Specificity Phosphatases; Liver; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Non-alcoholic Fatty Liver Disease; Osteoprotegerin; Racemethionine | 2023 |